Verus Financial Partners, Inc. Johnson & Johnson Transaction History

Verus Financial Partners, Inc.

$852 Million
Q1 2024

A detailed history of Verus Financial Partners, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Verus Financial Partners, Inc. holds 4,583 shares of JNJ stock, worth $671,317. This represents 0.09% of its overall portfolio holdings.

Number of Shares

4,583

Previous 4,819 4.9%

Holding current value

$671,317

Previous $755,000 4.11%

% of portfolio

0.09%

Previous 0.09%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$155.22 - $162.74 $36,631 - $38,406	-236 Reduced 4.9%	4,583 $724,000
Q4 2023 Feb 06, 2024	BUY	$145.6 - $158.88 $4,076 - $4,448	28 Added 0.58%	4,819 $755,000
Q3 2023 Oct 23, 2023	BUY	$155.75 - $174.48 $64,636 - $72,409	415 Added 9.48%	4,791 $746,000
Q2 2023 Jul 27, 2023	SELL	$154.35 - $166.11 $18,058 - $19,434	-117 Reduced 2.6%	4,376 $724,000
Q1 2023 May 05, 2023	SELL	$151.05 - $180.26 $45,315 - $54,078	-300 Reduced 6.26%	4,493 $696,000

Q4 2022 Feb 01, 2023	SELL	$160.2 - $179.79 $124,955 - $140,236	-780 Reduced 14.0%	4,793 $846,000
Q3 2022 Oct 31, 2022	SELL	$161.33 - $179.52 $69,049 - $76,834	-428 Reduced 7.13%	5,573 $925,000
Q2 2022 Aug 03, 2022	BUY	$168.19 - $186.01 $229,915 - $254,275	1,367 Added 29.5%	6,001 $1.03 Million
Q1 2022 Apr 15, 2022	SELL	$158.14 - $179.59 $13,758 - $15,624	-87 Reduced 1.84%	4,634 $834,000
Q4 2021 Jan 19, 2022	SELL	$155.93 - $173.01 $52,236 - $57,958	-335 Reduced 6.63%	4,721 $808,000
Q3 2021 Oct 29, 2021	BUY	$161.5 - $179.47 $15,988 - $17,767	99 Added 2.0%	5,056 $810,000
Q2 2021 Jul 23, 2021	BUY	$159.48 - $171.07 $55,180 - $59,190	346 Added 7.5%	4,957 $835,000
Q1 2021 Apr 27, 2021	SELL	$153.07 - $170.48 $47,604 - $53,019	-311 Reduced 6.32%	4,611 $754,000
Q4 2020 Feb 10, 2021	SELL	$137.11 - $157.38 $860,502 - $987,716	-6,276 Reduced 56.05%	4,922 $775,000
Q3 2020 Nov 03, 2020	BUY	$140.38 - $153.83 $961,603 - $1.05 Million	6,850 Added 157.54%	11,198 $1.67 Million
Q2 2020 Jul 31, 2020	SELL	$128.81 - $155.51 $10,562 - $12,751	-82 Reduced 1.85%	4,348 $611,000
Q1 2020 Apr 09, 2020	BUY	$111.14 - $153.99 $5,334 - $7,391	48 Added 1.1%	4,430 $581,000
Q4 2019 Jan 21, 2020	BUY	$127.5 - $146.44 $9,435 - $10,836	74 Added 1.72%	4,382 $639,000
Q3 2019 Oct 15, 2019	BUY	$126.95 - $142.14 $13,329 - $14,924	105 Added 2.5%	4,308 $557,000
Q2 2019 Aug 05, 2019	SELL	$131.15 - $144.24 $17,574 - $19,328	-134 Reduced 3.09%	4,203 $585,000
Q1 2019 Apr 19, 2019	BUY	$125.72 - $139.79 $71,408 - $79,400	568 Added 15.07%	4,337 $606,000
Q3 2018 Nov 09, 2018	SELL	$121.58 - $142.88 $27,963 - $32,862	-230 Reduced 5.75%	3,769 $521,000
Q2 2018 Jul 16, 2018	SELL	$119.4 - $131.76 $1,432 - $1,581	-12 Reduced 0.3%	3,999 $485,000
Q1 2018 Apr 23, 2018	BUY	$125.1 - $148.14 $25,020 - $29,627	200 Added 5.25%	4,011 $514,000
Q4 2017 Jan 29, 2018	BUY	$131.22 - $143.62 $11,153 - $12,207	85 Added 2.28%	3,811 $532,000
Q3 2017 Nov 03, 2017	BUY	$129.47 - $135.38 $482,405 - $504,425	3,726	3,726 $484,000

Others Institutions Holding JNJ

# of Institutions

4,148

Shares Held

1.64B

Call Options Held

15.1M

Put Options Held

12.1M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $383B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Verus Financial Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Verus Financial Partners, Inc. with notifications on news.

Account

Verus Financial Partners, Inc. Johnson & Johnson Transaction History